-
Je něco špatně v tomto záznamu ?
Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
A. Burgetova, P. Dusek, T. Uher, M. Vaneckova, M. Vejrazka, R. Burgetova, D. Horakova, B. Srpova, J. Krasensky, L. Lambert
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
NV18-08-00062
Ministry of Health of the Czech Republic
MH CZ-DRO, General University Hospital in Prague - VFN, 00064165
Ministry of Health of the Czech Republic
Cooperatio, Medical Diagnostics and Basic Medical Sciences
Charles University in Prague
n/A
Roche company
NLK
Directory of Open Access Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
- Publikační typ
- časopisecké články MeSH
Oxidative stress has been implied in cellular injury even in the early phases of multiple sclerosis (MS). In this study, we quantified levels of biomarkers of oxidative stress and antioxidant capacity in cerebrospinal fluid (CSF) in newly diagnosed MS patients and their associations with brain atrophy and iron deposits in the brain tissue. Consecutive treatment-naive adult MS patients (n = 103) underwent brain MRI and CSF sampling. Healthy controls (HC, n = 99) had brain MRI. CSF controls (n = 45) consisted of patients with non-neuroinflammatory conditions. 3T MR included isotropic T1 weighted (MPRAGE) and gradient echo (GRE) images that were processed to quantitative susceptibility maps. The volume and magnetic susceptibility of deep gray matter (DGM) structures were calculated. The levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), 8-iso prostaglandin F2α (8-isoPG), neutrophil gelatinase-associated lipocalin (NGAL), peroxiredoxin-2 (PRDX2), and malondialdehyde and hydroxyalkenals (MDA + HAE) were measured in CSF. Compared to controls, MS patients had lower volumes of thalamus, pulvinar, and putamen, higher susceptibility in caudate nucleus and globus pallidus, and higher levels of 8-OHdG, PRDX2, and MDA + HAE. In MS patients, the level of NGAL correlated negatively with volume and susceptibility in the dentate nucleus. The level of 8-OHdG correlated negatively with susceptibility in the caudate, putamen, and the red nucleus. The level of PRDX2 correlated negatively with the volume of the thalamus and both with volume and susceptibility of the dentate nucleus. From MRI parameters with significant differences between MS and HC groups, only caudate susceptibility and thalamic volume were significantly associated with CSF parameters. Our study shows that increased oxidative stress in CSF detected in newly diagnosed MS patients suggests its role in the pathogenesis of MS.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017038
- 003
- CZ-PrNML
- 005
- 20240903112951.0
- 007
- ta
- 008
- 220718s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/diagnostics12061365 $2 doi
- 035 __
- $a (PubMed)35741175
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Burgetova, Andrea $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000299752338 $7 xx0163957
- 245 10
- $a Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy / $c A. Burgetova, P. Dusek, T. Uher, M. Vaneckova, M. Vejrazka, R. Burgetova, D. Horakova, B. Srpova, J. Krasensky, L. Lambert
- 520 9_
- $a Oxidative stress has been implied in cellular injury even in the early phases of multiple sclerosis (MS). In this study, we quantified levels of biomarkers of oxidative stress and antioxidant capacity in cerebrospinal fluid (CSF) in newly diagnosed MS patients and their associations with brain atrophy and iron deposits in the brain tissue. Consecutive treatment-naive adult MS patients (n = 103) underwent brain MRI and CSF sampling. Healthy controls (HC, n = 99) had brain MRI. CSF controls (n = 45) consisted of patients with non-neuroinflammatory conditions. 3T MR included isotropic T1 weighted (MPRAGE) and gradient echo (GRE) images that were processed to quantitative susceptibility maps. The volume and magnetic susceptibility of deep gray matter (DGM) structures were calculated. The levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), 8-iso prostaglandin F2α (8-isoPG), neutrophil gelatinase-associated lipocalin (NGAL), peroxiredoxin-2 (PRDX2), and malondialdehyde and hydroxyalkenals (MDA + HAE) were measured in CSF. Compared to controls, MS patients had lower volumes of thalamus, pulvinar, and putamen, higher susceptibility in caudate nucleus and globus pallidus, and higher levels of 8-OHdG, PRDX2, and MDA + HAE. In MS patients, the level of NGAL correlated negatively with volume and susceptibility in the dentate nucleus. The level of 8-OHdG correlated negatively with susceptibility in the caudate, putamen, and the red nucleus. The level of PRDX2 correlated negatively with the volume of the thalamus and both with volume and susceptibility of the dentate nucleus. From MRI parameters with significant differences between MS and HC groups, only caudate susceptibility and thalamic volume were significantly associated with CSF parameters. Our study shows that increased oxidative stress in CSF detected in newly diagnosed MS patients suggests its role in the pathogenesis of MS.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dusek, Petr $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic $u Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic
- 700 1_
- $a Uher, Tomas $u Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000331609022 $7 xx0189534
- 700 1_
- $a Vaneckova, Manuela $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic
- 700 1_
- $a Vejrazka, Martin $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic
- 700 1_
- $a Burgetova, Romana $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic $u Department of Radiology, Third Faculty of Medicine, Charles University, 100 34 Prague, Czech Republic
- 700 1_
- $a Horakova, Dana $u Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic
- 700 1_
- $a Srpová, Barbora $u Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000280926625 $7 xx0321726
- 700 1_
- $a Krasensky, Jan $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic
- 700 1_
- $a Lambert, Lukas $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000322994707 $7 xx0145830
- 773 0_
- $w MED00195450 $t Diagnostics $x 2075-4418 $g Roč. 12, č. 6 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35741175 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20240903112947 $b ABA008
- 999 __
- $a ind $b bmc $g 1816417 $s 1168280
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 12 $c 6 $e 20220601 $i 2075-4418 $m Diagnostics $n Diagnostics $x MED00195450
- GRA __
- $a NV18-08-00062 $p Ministry of Health of the Czech Republic
- GRA __
- $a MH CZ-DRO, General University Hospital in Prague - VFN, 00064165 $p Ministry of Health of the Czech Republic
- GRA __
- $a Cooperatio, Medical Diagnostics and Basic Medical Sciences $p Charles University in Prague
- GRA __
- $a n/A $p Roche company
- LZP __
- $a Pubmed-20220718